People with severe sickle cell disease (SCD) have reported significant improvements in their quality of life after receiving the…
Articles by Marisa Wexler, MS
Correctsequence Therapeutics’ experimental gene-editing therapy CS-101 has been used to treat a person with sickle cell disease (SCD) for…
People with sickle cell disease (SCD) may have a higher risk of developing blood cancer, but a lower risk…
BEAM-101, a genetically modified cell therapy for sickle cell disease (SCD) that’s being tested in clinical trials, has been…
An algorithm that grew out of a collaboration between different specialties at the Medical University of South Carolina (MUSC) may…
Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of Lyfgenia (lovotibeglogene autotemcel), Bluebird’s gene therapy…
This year, for the first time, two teenagers in Florence, South Carolina, are going to be able to go swimming…
This month, the University of Tennessee Health Science Center College of Nursing is hosting a conference that aims to educate…
Scientists have discovered more than a dozen genes that regulate the production of fetal hemoglobin in people of African descent,…
Undergoing a bone marrow transplant during adolescence may reduce the risk of stroke in people with sickle cell disease…